[Current status of the study of genetic engineering in the hematology].
Shibata
A
A
Kishi
K
K
Koyama
S
S
Nagai
K
K
Aoki
S
S
Saito
H
H
Tatewaki
W
W
Sato
K
K
Furukawa
T
T
D001688:Biological Products / Q000627:therapeutic use*; D017977:Deltaretrovirus / Q000235:genetics; D004921:Erythropoietin / Q000627:therapeutic use; D005818:Genetic Engineering; D006678:HIV / Q000235:genetics; D006402:Hematologic Diseases / Q000235:genetics* / Q000628:therapy; D006801:Humans; D007136:Immunoglobulins / Q000235:genetics*; D007938:Leukemia / Q000235:genetics; D008223:Lymphoma / Q000235:genetics; D009857:Oncogenes; D011948:Receptors, Antigen, T-Cell / Q000235:genetics*; D014162:Transfection; D014178:Translocation, Genetic
D001688:Biological Products; D007136:Immunoglobulins; D011948:Receptors, Antigen, T-Cell; D004921:Erythropoietin